FY2026 EPS Estimates for McKesson Boosted by Zacks Research

Key Points

• Zacks Research has increased its FY2026 earnings per share estimate for McKesson to $37.19, up from a previous estimate of $37.12.
• Multiple investment firms have raised their price targets for McKesson, with Morgan Stanley setting a new target at $857.00 and recommending an "overweight" rating.
• McKesson recently declared a quarterly dividend of $0.82 per share, representing an annualized yield of 0.4%, increased from the previous dividend of $0.71.

McKesson Corporation (NYSE:MCK - Free Report) - Investment analysts at Zacks Research raised their FY2026 earnings per share estimates for shares of McKesson in a research report issued to clients and investors on Monday, October 6th. Zacks Research analyst Team now forecasts that the company will post earnings per share of $37.19 for the year, up from their prior forecast of $37.12. The consensus estimate for McKesson's current full-year earnings is $32.77 per share. Zacks Research also issued estimates for McKesson's Q4 2026 earnings at $10.68 EPS, Q3 2027 earnings at $10.26 EPS, FY2027 earnings at $40.37 EPS, Q1 2028 earnings at $9.45 EPS and FY2028 earnings at $47.20 EPS.

Other analysts have also recently issued reports about the company. Morgan Stanley increased their price objective on McKesson from $810.00 to $857.00 and gave the stock an "overweight" rating in a research report on Wednesday, September 24th. Wells Fargo & Company boosted their price objective on shares of McKesson from $772.00 to $816.00 and gave the company an "equal weight" rating in a research note on Wednesday, September 24th. Evercore ISI raised their target price on shares of McKesson from $800.00 to $825.00 and gave the stock an "outperform" rating in a research note on Wednesday, September 24th. Bank of America boosted their price target on shares of McKesson from $800.00 to $850.00 and gave the stock a "buy" rating in a research note on Wednesday, September 24th. Finally, Mizuho raised their price objective on shares of McKesson from $750.00 to $770.00 and gave the company a "neutral" rating in a research report on Wednesday, September 24th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $829.08.

McKesson Stock Performance

Shares of MCK opened at $740.82 on Tuesday. McKesson has a fifty-two week low of $482.44 and a fifty-two week high of $776.14. The firm has a 50-day simple moving average of $703.30 and a 200-day simple moving average of $704.05. The company has a market capitalization of $92.15 billion, a price-to-earnings ratio of 29.54, a price-to-earnings-growth ratio of 1.32 and a beta of 0.52.

McKesson (NYSE:MCK - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $8.26 EPS for the quarter, missing analysts' consensus estimates of $8.33 by ($0.07). McKesson had a net margin of 0.84% and a negative return on equity of 196.66%. The business had revenue of $97.83 billion during the quarter, compared to analyst estimates of $95.93 billion. During the same period in the previous year, the firm earned $7.88 earnings per share. The business's revenue was up 23.4% compared to the same quarter last year.

McKesson Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 1st. Shareholders of record on Tuesday, September 2nd were issued a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.4%. This is a positive change from McKesson's previous quarterly dividend of $0.71. The ex-dividend date of this dividend was Tuesday, September 2nd. McKesson's dividend payout ratio is currently 13.08%.

Insiders Place Their Bets

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of McKesson stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $663.67, for a total transaction of $218,347.43. Following the completion of the transaction, the chief accounting officer owned 657 shares in the company, valued at approximately $436,031.19. The trade was a 33.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Brian S. Tyler sold 19,371 shares of the firm's stock in a transaction that occurred on Friday, July 11th. The stock was sold at an average price of $708.09, for a total transaction of $13,716,411.39. Following the transaction, the chief executive officer directly owned 27,872 shares of the company's stock, valued at approximately $19,735,884.48. This trade represents a 41.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 43,560 shares of company stock valued at $30,438,602. Company insiders own 0.08% of the company's stock.

Institutional Trading of McKesson

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MCK. Oppenheimer Asset Management Inc. boosted its position in McKesson by 54.0% during the first quarter. Oppenheimer Asset Management Inc. now owns 4,541 shares of the company's stock worth $3,056,000 after acquiring an additional 1,592 shares during the last quarter. Dynamic Advisor Solutions LLC lifted its position in McKesson by 16.6% during the first quarter. Dynamic Advisor Solutions LLC now owns 778 shares of the company's stock worth $524,000 after buying an additional 111 shares during the period. Cambridge Investment Research Advisors Inc. boosted its stake in McKesson by 18.9% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 23,033 shares of the company's stock worth $15,501,000 after buying an additional 3,659 shares during the last quarter. Acadian Asset Management LLC grew its holdings in McKesson by 22.0% in the 1st quarter. Acadian Asset Management LLC now owns 378,926 shares of the company's stock valued at $254,979,000 after buying an additional 68,294 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its stake in shares of McKesson by 4.3% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 183,258 shares of the company's stock valued at $123,332,000 after acquiring an additional 7,556 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company's stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.